verminderd zijn bij gelijktijdig toedienen van geneesmiddelen met hypoglykemische activiteit, zoals orale bloedglucoseverlagende geneesmiddelen, salicylaten (bijvoorbeeld acetylsalicylzuur), sulfonamiden, bepaalde antidepressiva (monoamine-oxidase-remmers), bepaalde ACE-remmers (captopril, enalapril), angiotensine # receptor blokkers, bèta-blokkers, octreotide, of alcohol
Insulin requirements may be reduced in the presence of medicinal products with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine oxidase inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin # receptor blockers, beta-blockers, octreotide or alcoholEMEA0.3 EMEA0.3